Skip to main content
. 2018 Dec 28;17(2):2400–2408. doi: 10.3892/ol.2018.9871

Figure 7.

Figure 7.

Prognostic value of miR-372 and ATAD2 in RCC patients. (A) OS and (B) DFS of RCC patients with high and low miR-372 expression levels. (C) OS and (D) DFS of RCC patients with high and low ATAD2 expression levels.